Clinical Trial Update: Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the safety profile of iodopovidone as a pleurodesis agent for malignant pleural effusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Iodopovidone (povidone-iodine)

Snippet

Sponsor: Grupo de Pesquisa em Pleura e Oncologia Toracica | Conditions: Pleural Effusion, Malignant | Phase 4 | Status: COMPLETED